financetom
Business
financetom
/
Business
/
Pet Valu Reports Q4 Adjusted Diluted EPS of $0.54; Provides 2024 Outlook
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Pet Valu Reports Q4 Adjusted Diluted EPS of $0.54; Provides 2024 Outlook
Mar 5, 2024 4:49 AM

07:38 AM EST, 03/05/2024 (MT Newswires) -- Pet Valu Holdings Ltd. ( PTVLF ) , a Canadian specialty retailer of pet food and pet-related supplies, on Tuesday reported its Q4 2023 results.

The company reported quarterly revenue of $287 million, compared with $266 million, last year.

Net income was $29 million, or $0.40 per diluted share, versus net income of $26 million, or $0.36 per diluted share, for Q4 2022.

Adjusted net income was $39.1 million, or $0.54 per adjusted diluted share, The comparable figures for the prior year were $31.1 million or $0.43 per adjusted diluted share.

System-wide sales were $379 million, a 5.1% increase YoY. Same-store sales growth was 1.9%, driven by same-store average spend per transaction growth.

The Board of Directors declared a dividend of $0.11 per common share.

For the full year 2024, Pet Valu ( PTVLF ) expects:

Revenue between $1.11 and $1.14 billion, supported by same-store sales growth of between 2% and 5%, 40 to 50 new store openings and higher wholesale merchandise sales penetration with Chico franchisees;

Adjusted net Income per diluted share between $1.57 and $1.63.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Copyright 2023-2026 - www.financetom.com All Rights Reserved